P-glycoprotein transporter expression on A549 respiratory epithelial cells is positively correlated with intracellular dexamethasone levels

Journal of Investigative Medicine

Volumn 58, Issue 8, 2010, Pages 991-994

  Cohen, Joanna S ^a,b   Benton, Angela S ^c   Nwachukwu, Fisayo ^d   Ozedirne, Tugba ^e   Teach, Stephen J ^a,b   Freishtat, Robert J ^a,b,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; Glucocorticoids; P glycoprotein

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLYCOPROTEIN P; SMALL INTERFERING RNA;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM;

EID: 78651499250     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181f88503     Document Type: Article

References (36)

1. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J. 1998;12(5):1209.
2. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373(9678):1905.
3. Chung KF, Godard P, Adelroth E, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J. 1999;13(5):1198.
4. Sousa AR, Lane SJ, Cidlowski JA, et al. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol. 2000;105(5):943.
5. Goleva E, Hauk PJ, Hall CF, et al. Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol. 2008;122(3):550.
6. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2006;117(3):522.
7. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976;455(1):152.
8. Gros P, Croop J, Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell. 1986;47(3):371.
9. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67.
10. Mason BL, Pariante CM, Thomas SA. A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice. Endocrinology. 2008;149(10):5244.
11. Oka A, Oda M, Saitoh H, et al. Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells. Biol Pharm Bull. 2002;25(3):393.
12. Ueda K, Okamura N, Hirai M, et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem. 1992;267(34):24248.
13. Farrell RJ, Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol. 2003;178(3):339.
14. Farrell RJ, Murphy A, Long A, et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 2000;118(2):279.
15. Tsujimura S, Saito K, Nawata M, et al. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis. 2008;67(3):380.
16. Lechapt-Zalcman E, Hurbain I, Lacave R, et al. MDR1-Pgp 170 expression in human bronchus. Eur Respir J. 1997;10(8):1837.
17. Montano E, Schmitz M, Blaser K, et al. P-glycoprotein expression in circulating blood leukocytes of patients with steroid-resistant asthma. J Investig Allergol Clin Immunol. 1996;6(1):14.
18. Manford F, Riffo-Vasquez Y, Spina D, et al. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice. J Pharm Pharmacol. 2008;60(10):1305.
19. Madlova M, Bosquillon C, Asker D, et al. In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity. J Pharm Pharmacol. 2009;61(3):293.
20. van der Deen M, de Vries EGE, Timens W, et al. ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res. 2005;6:59.
21. van der Deen M, Timens W, Timmer-Bosscha H, et al. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice. Respir Res. 2007;8:49.
22. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med. 2003;139(5 Pt 1):359.
23. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711.
24. Lane SJ, Lee TH. Mononuclear cells in corticosteroid-resistant asthma. Am J Respir Crit Care Med. 1996;154(2 Pt 2): S49.
25. Malchoff DM, Brufsky A, Reardon G, et al. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest. 1993;91(5):1918.
26. Campbell L, Abulrob A-NG, Kandalaft LE, et al. Constitutive expression of P-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharmacol Exp Ther. 2003;304(1):441.
27. Scheffer GL, Pijnenborg ACLM, Smit EF, et al. Multidrug resistance related molecules in human and murine lung. J Clin Pathol. 2002;55(5):332.
28. van der Valk P, van Kalken CK, Ketelaars H, et al. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Ann Oncol. 1990;1(1):56.
29. Lehmann T, Kohler C, Weidauer E, et al. Expression of MRP1 and related transporters in human lung cells in culture. Toxicology. 2001;167(1):59.
30. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22(4):336.
31. Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med. 2004;350(13):1296.
32. Litman T, Druley TE, Stein WD, et al. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci. 2001;58(7):931.
33. Florea BI, van der Sandt IC, Schrier SM, et al. Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3). Br J Pharmacol. 2001;134(7):1555.
34. Hamilton KO, Backstrom G, Yazdanian MA, et al. P-glycoprotein efflux pump expression and activity in Calu-3 cells. J Pharm Sci. 2001;90(5):647.
35. 3-treated Calu-3 cell monolayers: modulation of P-glycoprotein activity. Pharm Res. 2002;19(11):1696.
36. Kopriva F, Dzubak P, Potesil J, et al. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children. J Asthma. 2009;46(4):366.